Nathalie Maubon, PhD (Linkedin profil)
With a 15-year experience in pharmaceutical research (public research, pharmaceutical industry and biotechnology company), Nathalie Maubon is a specialist in the development and automation of robust models for high-throughput screening in HCS , HTS and ADMET area. She has held several positions from managing projects to general direction, via managing teams and services.
Julian Bursztyka, PhD (Linkedin profil)
After a PhD on biotransformation of endocrine disruptors in in vitro models used to screen them, Julian strenghened his expertise in the ADMET area and in pharmacology by working 5 years in the CRO industry. Over those years, he took a liking for helping the clients achieve their goals, through talks and the practice of science, within the constraints of time and finance.
Discover our services